These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 27068887

  • 21. Hearing loss after intratympanic gentamicin therapy for unilateral Ménière's Disease.
    Martin E, Perez N.
    Otol Neurotol; 2003 Sep; 24(5):800-6. PubMed ID: 14501459
    [Abstract] [Full Text] [Related]

  • 22. Intratympanic gentamicin therapy for Ménière's disease: a meta-analysis.
    Chia SH, Gamst AC, Anderson JP, Harris JP.
    Otol Neurotol; 2004 Jul; 25(4):544-52. PubMed ID: 15241234
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Vestibular nerve section versus intratympanic gentamicin for Meniere's disease.
    Hillman TA, Chen DA, Arriaga MA.
    Laryngoscope; 2004 Feb; 114(2):216-22. PubMed ID: 14755193
    [Abstract] [Full Text] [Related]

  • 25. Differences in responsiveness of intratympanic steroid injection for intractable vertigo in Meniere's disease.
    Okuda H, Aoki M, Ogawa B, Shibata H, Ueda N, Ohashi T, Hayashi H, Nishihori T, Kuze B, Ogawa T.
    Am J Otolaryngol; 2021 Feb; 42(6):103141. PubMed ID: 34171697
    [Abstract] [Full Text] [Related]

  • 26. Intratympanic gentamicin therapy for intractable Ménière's disease.
    De Beer L, Stokroos R, Kingma H.
    Acta Otolaryngol; 2007 Jun; 127(6):605-12. PubMed ID: 17503229
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Intratympanic gentamicin therapy for persistent vertigo after endolymphatic sac surgery.
    Marzo SJ, Leonetti JP.
    Otolaryngol Head Neck Surg; 2002 Jan; 126(1):31-3. PubMed ID: 11821762
    [Abstract] [Full Text] [Related]

  • 29. Intratympanic therapy for Ménière's disease. High-concentration gentamicin with round-window protection.
    Quaranta A, Aloisi A, De Benedittis G, Scaringi A.
    Ann N Y Acad Sci; 1999 Nov 28; 884():410-24. PubMed ID: 10842610
    [Abstract] [Full Text] [Related]

  • 30. Intratympanic gentamicin for treatment of intractable Meniere's disease: a preliminary report.
    Rauch SD, Oas JG.
    Laryngoscope; 1997 Jan 28; 107(1):49-55. PubMed ID: 9001265
    [Abstract] [Full Text] [Related]

  • 31. Intratympanic Gentamicin for Small Vestibular Schwannomas With Intractable Vertigo.
    Yang J, Jia H, Li G, Huang M, Zhu W, Wang Z, Li Y, Wu H.
    Otol Neurotol; 2018 Sep 28; 39(8):e699-e703. PubMed ID: 30020264
    [Abstract] [Full Text] [Related]

  • 32. Intratympanic gentamicin injection for the treatment of Meniere's disease.
    Youssef TF, Poe DS.
    Am J Otol; 1998 Jul 28; 19(4):435-42. PubMed ID: 9661751
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Angular vestibulo-ocular reflex gains correlate with vertigo control after intratympanic gentamicin treatment for Meniere's disease.
    Lin FR, Migliaccio AA, Haslwanter T, Minor LB, Carey JP.
    Ann Otol Rhinol Laryngol; 2005 Oct 28; 114(10):777-85. PubMed ID: 16285268
    [Abstract] [Full Text] [Related]

  • 35. Vestibular results after intratympanic gentamicin therapy in disabling Menière's disease.
    Junet P, Karkas A, Dumas G, Quesada JL, Schmerber S.
    Eur Arch Otorhinolaryngol; 2016 Oct 28; 273(10):3011-8. PubMed ID: 26780342
    [Abstract] [Full Text] [Related]

  • 36. Intentional ablation of vestibular function using commercially available topical gentamicin-betamethasone eardrops in patients with Meniere's disease: further evidence for topical eardrop ototoxicity.
    Kaplan DM, Hehar SS, Bance ML, Rutka JA.
    Laryngoscope; 2002 Apr 28; 112(4):689-95. PubMed ID: 12150525
    [Abstract] [Full Text] [Related]

  • 37. Recovery of subjective visual horizontal after unilateral vestibular deafferentation by intratympanic instillation of gentamicin.
    Takai Y, Murofushi T, Ushio M, Iwasaki S.
    J Vestib Res; 2006 Apr 28; 16(1-2):69-73. PubMed ID: 16917170
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Long-term Vertigo Control and Vestibular Function After Low-dose On-demand Transtympanic Gentamicin for Refractory Menière's Disease.
    Nicolas S, Kmeid M, Mansour C, Fraysse B, Deguine O, Marx M, Fraysse ME.
    Otol Neurotol; 2019 Feb 28; 40(2):218-225. PubMed ID: 30624404
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.